POSTER SESSION II
Monday, March 26, 2007 — 1:00 PM - 4:30 PM
Convention Center, Exhibit Hall B - 1
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
...then notice the 'Event Added' prompt in the toolbar above as feedback:
GYNECOLOGIC PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
105
The Bethesda System 2001 Recommendation of Reporting Endometrial Cells Seen in Pap Tests of Women Age 40 Years and Older Is Overly Conservative
(861)
DL Aslan, JP Crapanzano, M Harshan, M Erroll, B Vakil, EC Pirog - New York Presbyterian Hospital Weill-Cornell Medical Center, New York, NY
Diagnosing Endometrial Hyperplasia: Why Is It so Difficult To Agree?
(854)
KH Allison, SD Reed, L Voigt, RL Garcia - University of Washington Medical Center and Fred Hutchinson Cancer Research Center, Seattle, WA
Should Intraoperative Frozen Section Diagnosis Be Used To Determine Surgical Staging for Patients with Endometrial Carcinoma?
(852)
R Ali-Fehmi, MH Arabi, RT Morris, VL Schimp, CS Bryant, JP Shah, AR Munkarah, W Sakr - Karmanos Cancer Center, Wayne State University, Detroit, MI
Comparison of Kurman-Norris and EIN Classification Systems for Predicting Myometrial Invasion in Endometrial Carcinoma
(977)
DM Selby, JC Shaw, CM Zahn, B Kendall - Wilford Hall Medical Center, Lackland AFB, TX; USUHS, Bethesda, MD
Reproducibility of the Diagnosis of Atypical Endometrial Hyperplasia and Endometrioid Adenocarcinoma: A Multi-Institutional Study for Conservative Therapy
(900)
M Fukunaga, H Tsuda, A Sakamoto, T Kaku, K Ushijima, T Kamura, H Yoshikawa - Jikei University Daisan Hospital, Komae, Tokyo, Japan; National Defense Medical University, Tokorozawa, Saitama, Japan; Kyorin University, Mitaka, Tokyo, Japan; Kyushu University, Fukuoka, Japan; Kurume Medical University, Kurume, Fukuoka, Japan; Tsukuba University, Tsukuba, Ibaraki, Japan
Reproducibility of the Diagnosis of Atypical Endometrial Hyperplasia and Endometrioid Adenocarcinoma with Histologic Effects of Hormonal Therapy of Medroxyprogesterone Acetate
(899)
M Fukunaga, H Tsuda, A Sakamoto, T Kaku, K Ushijima, T Kamura, H Yoshikawa - Jikei University Daisan Hospital, Komae, Tokyo, Japan; National Defense Medical University, Tokorozawa, Saitama, Japan; Kyorin University, Mitaka, Tokyo, Japan; Kyushu University, Fukuoka, Japan; Kurume Medical University, Kurume, Fukuoka, Japan; Tsukuba University, Tsukuba, Ibaraki, Japan
Conservative Therapy for Stage 1 Adenocarcinoma of the Endometrium in Young Women: Clinicopathologic Study
(932)
RS Kulkarni, EM Ongcapin - St Barnabas Medical Center, Livingston, NJ
The Clinical and Pathologic Features of Non-Invasive and Superficially Invasive Adenocarcinoma of Endometrium. A Study of 44 Cases
(923)
MW Jones, GA Trucco - Magee Womens Hospital of UPMC, Pittsburgh, PA
Cervical Involvement by Non-Myoinvasive [Otherwise FIGO Stage 1A] Uterine Endometrioid Carcinoma: Incidence and Prognostic Significance
(896)
O Fadare, L Desrosiers, F Xiao, SA Wang - Wilford Hall Medical Center, Lackland AFB, TX; University of Massachusetts, Worcester, MA
Lymphovascular Invasion Is a Significant Predictor for Recurrence in Patients with Early Stage Endometrial Endometrioid Adenocarcinoma
(953)
S Nofech-Mozes, Z Ghorab, N Ismiil, I Ackerman, G Thomas, A Covens, MA Khalifa - University of Toronto, Toronto, ON, Canada
Endometrial Carcinoma in Women 35 Years of Age or Younger
(851)
R Ali-Fehmi, M Cote, MH Arabi, CS Bryant, JP Shah, L Mughrabi, VL Schimp, K Sauder, F Abdul-Karim, AR Munkarah - Karmanos Cancer Center, Wayne State Universtiy, Detroit, MI; Case Western University Hospital, Cleveland, OH
Estrogen Receptor Co-Activators and Co-Repressors in Endometrial Carcinoma Associated with Tamoxifen Therapy
(884)
S Dahiya, E Carney, E Lopez-Varela, E Oliva, X-J Ma, DC Sgroi - Massachusetts General Hospital, Boston, MA; AviaraDx Inc, Carlsbad, CA
Immunohistochenical Analysis of Mismatch Repair Genes in Premenopausal Women with Endometrial Endometrioid Adenocarcinoma
(952)
S Nofech-Mozes, Z Ghorab, E Hsieh, I Ackerman, G Thomas, A Covens, MA Khalifa - University of Toronto, Toronto, ON, Canada
Microsatellite Instability and PTEN Expression in Mucinous Endometrioid Adenocarcinomas
(874)
HP Cathro, MH Stoler - University of Virginia, Charlottesville, VA
PIK3CA Mutations Are Associated with PTEN Alterations and Correlate with Microsatellite Instability in Endometrial Carcinomas
(902)
A Gallardo, LL Catasus, A Ribe, A Gonzalez, J Munoz, M Cuatrecasas, J Prat - Hospital de la Santa Creu i Sant Pau. Autonomous University of Barcelona, Barcelona, Spain
Microsatellite Instability Is Associated with K-RAS Transition Mutations in Endometrioid Carcinomas
(873)
LL Catasus, A Ribe, A Gallardo, M Cuatrecasas, J Prat - Hospital de la Santa Creu i Sant Pau. Autonomous University of Barcelona, Barcelona, Spain
Reduced Expression of RASSF1A and Spry-2 in Endometrial Carcinoma
(957)
J Pallares, A Velasco, X Dolcet, D Llobet, M Encinas, S Puente, V Palomar, X Matias-Guiu - Hospital Universitari Arnau de Vilanova/University of Lleida, Lleida, Spain
Inverse Relationship between Epithelial and Stromal Expression of CD44 and Clinical outcome in Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study
(850)
A Akalin, K Darcy, B Brady, KC Torkko, K Leslie, CW Whitney, M Singh - University of Colorado at Denver and Health Sciences Center, Aurora, CO; Gynecologic Oncology Group, Buffalo, NY; University of New Mexico, Albuqurque, NM; Christiana Gynecologic Oncology, LLC, Newark, DE
Utility of Immunohistochemical Markers in the Differential Diagnosis of Uterine Papillary Serous Carcinomas and Endometrioid Carcinomas of the Endometrium
(983)
DE Song, KR Kim - University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea
Epidermal Growth Factor Receptor Protein Overexpression Is Significant in Endometrial Carcinosarcoma in Contrast to Other Endometrial Carcinomas and Is Not Associated with EGFR Gene Amplification
(878)
DA Chitale, RA Soslow - Memorial Sloan Kettering Cancer Center, New York, NY
Clinicopathologic Features of Endometrial Serous Carcinoma in Women Younger Than 56 Years of Age
(940)
S Liang, C Tornos, M Pearl, E Chalas, M Kelly, P Schwartz, T Zhang, W Zheng - State University of New York, Stony Brook; Yale University; Shangdon University; University of Arizona, Tucson, AZ
Endometrial Serous Carcinoma with a Tubuloglandular Pattern: An Underrecognized Form of Aggressive Endometrial Cancer
(1005)
W Zheng, M Kelly, X Yi, O Fadare, PE Schwartz, Z Jiang, SX Liang - University of Arizona, Tucson, AZ; Yale University, New Haven, CT; Fudan University, China; Wilford Hall Hospital, Lackland AFB, TX; UMASS, Worcester, MA; SUNY, Stonybrook, NY
The RNA-Binding Protein IMP3: A Novel Cytoplasmic Marker for Endometrial Serous Carcinoma
(1006)
W Zheng, X Yi, S Liang, M Kelly, P Schwartz, Z Jiang - University of Arizona, Tucson; Fudan University, Shanghai, China; State Univeristy of New York at Stony Brook; Yale University; University of Massachusetts Medical Center
IMP3: A Novel Molecular Marker That Distinguishes Endometrial Serous Carcinoma from Benign and Other Malignant Lesions of the Endometrium
(981)
S Singh, W Zheng, J Wang, SK Chambers, J McAlpine, Z Jiang - U of Arizona, Tucson; Shanghai Med College Fudan Univ, Shanghai, China; Tufts-New England Med Center, Boston; Yale Univ School of Med, New Haven; U of Mass, Worcester
p16 Expression in Squamous and Trophoblastic Lesions of the Upper Female Genital Tract
(963)
MD Post, SG Carinelli, S Campbell, RA Soslow, E Oliva - Massachusetts General Hospital, Boston, MA; Fondazione Ospedale Policlinico, Mangiagalli e Regina Elena, Milano, Italy; Memorial Sloan-Kettering Cancer Center, New York, NY
Differential Expression of Vimentin in Ovarian and Uterine Adenocarcinomas
(950)
F Mohammadi, MC Ionescu - North Shore- Long Island Jewish Health System, Manhasset, NY
Molecular Analysis of Simultaneous Adenocarcinomas of the Ovary and Endometrium
(926)
M Kapali, S Dacic, N Esposito, G Mantha, MW Jones - Magee Womens Hospital of the University of Pittsburgh, Pittsburgh, PA
Immunohistochemical Comparisson of Serous Carcinomas of Ovary Versus Endometrium
(918)
DN Ionescu, I Chebib, A Alkushi, AM Gown, CB Gilks - BC Cancer Agency, Vancouver, BC, Canada; University of Calgary, Calgary, AB, Canada; PhenoPath Laboratories and IMPRIS, Seattle, WA; Vancouver General Hospital, Vancouver, BC, Canada; King Fahad National Guard Hospital, Riyadh, Saudi Arabia
The Morphologic Spectrum of Smooth Muscle Tumors in the Hereditary Leimyomatosis and Renal Cell Cancer Syndrome. Its Clinical Significance
(990)
D Val, P Stratton, RD Neumann, WM Linehan, MJ Merino - NCI, Bethesda, MD; NIH, Bethesda, MD; CC, Bethesda, MD; NCI, NIH, Bethesda, MD
The Alleged Low-Grade Leiomyosarcomas of the Female Genital Tract: Metastatic Lesions or Independent Primary Tumors?
(961)
L Posligua, A Malpica, M Deavers, M Merino, E Silva - M.D. Anderson Cancer Center, Houston, TX; National Institute of Health, Bethesda, MD
Mitosis-Specific Marker Phospho-Histone H3 (pHH3) in the Assessment of Mitotic Index in Uterine Smooth Muscle Tumors
(992)
E Veras, A Malpica, MT Deavers, EG Silva - The University of Texas Medical School, Houston, TX; The University of Texas MD Anderson Cancer Center, Houston, TX
The Role of PTEN in the Pathogenesis of Uterine Smooth Muscle Malignancies: A Comparative Immunohistochemical Study of 44 Cases of Low Grade, High Grade, and Epithelioid Leiomyosarcomas
(965)
MR Quddus, CJ Sung, MM Steinhoff, WD Lawrence - Women & Infants Hospital/Brown Medical School, Providence, RI
Utility of Trichrome and Reticulum Stains in Characterizing Necroses in Uterine Smooth Muscle Tumors
(904)
HG Gao, VA LiVolsi, PJ Zhang - Hospital of the University of Pennsylvania, Philadelphia, PA
Differential Expression of Insulin Liked Growth Factor 1 In Uterine Leiomyomas Is Regulated by MIR-29B
(995)
YH Wen, A Wei, J Laser, K Mittal, JJ Wei - New York University School of Medicine, New York, NY; University of Pennsylvania, Philadelphia, PA
Differential Expression of microRNAs let-7c and miR21 in Benign, Atypical and Malignant Uterine Smooth Muscle Tumors
(960)
L Peng, P Lee, K Mittal, JJ Wei - New York University School of Medicine, New York, NY
Uterine Leiomyosarcomas Are Characterised by High p16, p53 and MIB1 Expression in Comparison to Usual Leiomyomas, Benign Leiomyoma Variants and Smooth Muscle Tumours of Uncertain Malignant Potential
(954)
CJ O’Neill, HA McBride, LE Connolly, WG McCluggage - Royal Group of Hospitals Trust, Belfast, Northern Ireland, United Kingdom
Uterine Tumors Resembling Ovarian Sex Cord Tumors Frequently Have Incorporated Mature Smooth Muscle Imparting a Pseudoinfiltrative Appearance
(971)
SE Rollins, PB Clement, RH Young - Massachusetts General Hospital, Boston, MA; Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada
Calretinin and CD34 Immunoreactivity of the Endometrial Stroma in Dysfunctional Bleeding and in Hyperplastic and Neoplastic Endometrial Lesions
(987)
I Teo, A Elkeilani, EC Marginean, J Thomas, KT Mai - Ottawa Civic Hospital, Ottawa, ON, Canada; University of Ottawa, Ottawa, ON, Canada
Analysis of EGFR Status in Endometrial Stromal Sarcoma
(882)
P Cossu-Rocca, F Pili, A Festa, M Contini, A Mura, L Bosincu, M Brunelli, G Martignoni, G Massarelli - University of Sassari, Sassari, Italy; University of Verona, Verona, Italy
Low-Grade Endometrial Stromal Sarcoma: Is There an Immunophenotype Predictive of Clinical Behavior?
(883)
S Dahiya, A Felix, P Branton, S Campbell, DC Sgroi, E Oliva - Massachusetts General Hospital, Boston, MA; Portuguese Oncologic Institute, Lisbon, Portugal; Inova Fairfax Hospital, Falls Church, VI
button next to any title to add to Itinerary Planner...
Add
